Home › Funds › Banco Santander, S.A. › VRTX

Banco Santander, S.A. position in VRTX

VERTEX PHARMACEUTICALS INC · Health Care

Banco Santander, S.A. reported holding 113,437 shares of VRTX (VERTEX PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$59.3M, representing 0.31% of its reported portfolio and ranking #48 among its reported holdings. Banco Santander, S.A. has disclosed VRTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)113.44K sh
Reported value held$59.31M
Portfolio Weight0.31%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Banco Santander, S.A.'s VRTX position evolved

Banco Santander, S.A. first disclosed a stake in VRTX in Q3 2023 at 22,555 shares (US$7.8M). The position peaked in Q3 2026 at 113,437 shares, worth US$59.3M. Across 13 filings, Banco Santander, S.A. increased the stake 8 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 113,437 shares valued at US$59.3M — an increase of 5,362 shares quarter over quarter.. Notable position changes include a 204% increase in Q4 2024 (shares rose 20% over the following quarter), a 33% increase in Q1 2025 (shares fell 8% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 22.55K $7.84M New
Q4 2023 20.39K $8.30M Reduce
Q1 2024 16.95K $7.09M Reduce
Q2 2024 16.43K $7.70M Reduce
Q3 2024 15.87K $7.38M Reduce
Q4 2024 48.18K $19.40M Add
Q1 2025 64.03K $31.04M Add
Q2 2025 70.19K $31.25M Add
Q3 2025 79.41K $31.10M Add
Q4 2025 98.03K $44.44M Add
Q1 2026 99.39K $44.38M Add
Q2 2026 108.08K $53.68M Add
Q3 2026 113.44K $59.31M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VRTX and 13F data

VRTX (VERTEX PHARMACEUTICALS INC) is a Health Care company. 32 other funds we track also report a position in VRTX — the largest reported positions include Capital World Investors (US$13.58B), Capital World Investors (US$12.97B), Capital Research Global Investors (US$9.68B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VRTX

All VRTX fund holders →

FAQ

How long has Banco Santander, S.A. held VRTX?

Banco Santander, S.A. has disclosed VRTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Banco Santander, S.A.'s current position in VRTX?

As of Q3 2026, Banco Santander, S.A. holds 113.44K shares of VRTX (VERTEX PHARMACEUTICALS INC), valued at $59.31M, representing 0.31% of its reported portfolio and ranking #48.

Has Banco Santander, S.A. been buying or selling VRTX?

In the latest 13F filing (Q3 2026), Banco Santander, S.A. increased its position in VRTX. The position peaked in Q3 2026 at 113.44K shares.

Which other funds hold VRTX?

Other major institutional holders of VRTX include Capital World Investors, Capital World Investors, Capital Research Global Investors, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.